Pharmaceuticals, among other products, will not be subject to the reciprocal tariffs, according to a White House fact sheet ...

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

Warrior Met Coal, Inc. stands strong with low-cost production, a robust balance sheet, and the promising Blue Creek project.

Billionaire entrepreneur and co-founder of Cost Plus Drugs, Mark Cuban's apprehensions of having to raise medicine prices in response to Trump's reciprocal tariffs on India is put to rest.

Rights Mar 16, 2016 Mar 17, 2016 May 12, 2015 Rights ratio: 5 share for every 116 held at a price of Rs 245.0 Rights Aug 23, 2012-Jul 14, 2011 Rights ratio: 1 share for every 7 held at a price of Rs ...

JPMorgan would like to be lighter in IT positioning as it expects financial year 2026 to be a complete washout.

Annual Report/Annual ResultsAPONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned 31.03.2025 / 14:00 CET/CESTThe issuer is solely ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,417.45 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Nordic American Tankers offers a ~10% dividend yield, 21 Suezmax tankers, and strong performance amid global growth. Learn ...

(Nasdaq: VINC) today announced that the previously signed binding Term Sheet between ... clinical-stage company developing Vincerx Pharma (VINC) announced plans to implement cost-controls and ...

SCCL falls short of coal production target due to external factors, focusing on technology and diversification for future ...